Last updated on October 2017

Phase III, Randomized, Double-Blind, Placebo-Controlled, Multicenter Study to Evaluate the Efficacy (Maintenance of Remission) and Safety of Etrolizumab Compared With Placebo in Patients With Moderate to Severe Active Ulcerative Colitis Who Are Naïve to TNF Inhibitors

Find a site near you

Start Over

Gastro Florida

3001 Executive Dr suite 130 Clearwater, FL USA
  Connect »